DCF — ST. JOSEPHS MEDICAL CENTER
Enterprise Value: $293.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$293.0M
Enterprise Value
$67.6M
PV of Cash Flows
$225.4M
PV of Terminal Value
$363.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $750.4M | $46.9M | 6.0% | $8.1M | $7.4M |
| Year 2 | $772.9M | $56.1M | 7.0% | $14.2M | $11.7M |
| Year 3 | $796.1M | $65.7M | 8.0% | $20.6M | $15.4M |
| Year 4 | $819.9M | $71.8M | 9.0% | $24.3M | $16.6M |
| Year 5 | $844.5M | $76.0M | 9.0% | $26.6M | $16.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $293.0M. Terminal value accounts for 77% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$728.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.05754230013425425
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5